Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Clinical trial data released today highlights a successful Phase II trial evaluating a novel RNA interference (RNAi) therapeutic targeted at hepatic inflammation pathways.
Targeted Liver Delivery Mechanism
Patients receiving quarterly subcutaneous injections demonstrated a median 45% reduction in high-sensitivity C-reactive protein. Crucially, broad immune cell function remained unaffected throughout the six-month observation window.
The Myth Debunked: It is vital another myth that draws on on a complete misunderstanding of how the…
GLP-1 success triggers massive R&D reallocations toward metabolic and cardiovascular disease treatments.
If you’ll be able to roof over your head, be glad. If you are able to put food…
Clinical trial results show high efficacy in monoclonal antibody therapies targeting autoimmune inflammatory pathways.
Once you’ve completely relaxed, and the mind is calm, bring to mind a being, or a force, that…
Automated high-throughput screening tools are reducing early-stage drug discovery timelines by up to 40 percent.